Portfolio (Quarterly)
Guide ↗
Rosalind Advisors, Inc.
· CIK 0001622627| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 | MYO | MYOMO INC | Healthcare | 3,839,772.0 | $3.5M | 1.23% | NEW | — | $0.91 | +13.2% |
| 22 | — PUT | INVESCO QQQ TR | — | 450,000.0 | $3.0M | 1.06% | NEW | — | $6.73 | — |
| 23 | — | POLYPID LTD | — | 696,556.0 | $3.0M | 1.06% | NEW | — | $4.34 | — |
| 24 | — | ONKURE THERAPEUTICS INC | — | 730,488.0 | $2.1M | 0.74% | NEW | — | $2.90 | — |
| 25 | — PUT | SPDR S&P 500 ETF TR | — | 510,000.0 | $1.9M | 0.66% | NEW | — | $3.70 | — |
| 26 | — PUT | ANAVEX LIFE SCIENCES CORP | — | 1,168,600.0 | $1.9M | 0.66% | NEW | — | $1.61 | — |
| 27 | — | REGENTIS BIOMATERIALS LTD | — | 251,510.0 | $1.7M | 0.60% | NEW | — | $6.74 | — |
| 28 | — PUT | SPDR SERIES TRUST | — | 1,937,600.0 | $1.3M | 0.47% | NEW | — | $0.70 | — |
| 29 | TRVI | TREVI THERAPEUTICS INC | Healthcare | 100,000.0 | $1.3M | 0.44% | NEW | — | $12.52 | +14.1% |
| 30 | — PUT | ISHARES TR | — | 200,000.0 | $1.1M | 0.39% | NEW | — | $5.56 | — |
| 31 | NRXS | NEURAXIS INC | Healthcare | 286,138.0 | $1.0M | 0.36% | NEW | — | $3.63 | +104.6% |
| 32 | KURA | KURA ONCOLOGY INC | Healthcare | 100,000.0 | $1.0M | 0.36% | NEW | — | $10.39 | +6.5% |
| 33 | GUTS | FRACTYL HEALTH INC | Healthcare | 385,731.0 | $849K | 0.30% | NEW | — | $2.20 | -60.2% |
| 34 | — | BIOFRONTERA INC | — | 1,140,764.0 | $650K | 0.23% | NEW | — | $0.57 | — |
| 35 | — CALL | ARRIVENT BIOPHARMA INC | — | 107,900.0 | $540K | 0.19% | NEW | — | $5.00 | — |
| 36 | — CALL | VERASTEM INC | — | 268,600.0 | $160K | 0.06% | NEW | — | $0.59 | — |
| 37 | — CALL | UNIQURE NV | — | 100,000.0 | $95K | 0.03% | NEW | — | $0.95 | — |
| 38 | — CALL | REPLIMUNE GROUP INC | — | 230,900.0 | $12K | 0.00% | NEW | — | $0.05 | — |
| 39 | — CALL | VIKING THERAPEUTICS INC | — | 100,000.0 | $2K | 0.00% | NEW | — | $0.02 | — |
| 40 | — PUT | REPLIMUNE GROUP INC | — | 264,700.0 | — | — | NEW | — | — | — |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%